INMED PHARMACEUTICALS
InMed Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol ("CBN") in diseases with high unmet medical needs. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based medicines.
INMED PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1981-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.inmedpharma.com
Total Employee:
11+
Status:
Active
Contact:
(604) 669-7207
Total Funding:
57.52 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Wordpress Plugins
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Catalyst Biosciences
Catalyst Biosciences is a drug r and d company creating catalytic biopharmaceutical products based on engineered human proteases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-09-13 | BayMedica | BayMedica acquired by InMed Pharmaceuticals | N/A |
Investors List
National Research Council of Canada Industrial Research Assistance Program
National Research Council of Canada Industrial Research Assistance Program investment in Grant - InMed Pharmaceuticals
Eight Capital
Eight Capital investment in Post-IPO Equity - InMed Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.inmedpharma.com Semrush global rank: 2.44 M Semrush visits lastest month: 7.36 K
- Host name: 162.223.226.26
- IP address: 162.223.226.26
- Location: Vancouver Canada
- Latitude: 49.245
- Longitude: -123.1337
- Timezone: America/Vancouver
- Postal: V6H
More informations about "InMed Pharmaceuticals"
About - InMed Pharmaceuticals
InMed’s has discovered a diverse pipeline of drug candidates across a spectrum of diseases with high unmet medical needs, which are currently at various stages of clinical and preclinical development:. INM-755, our lead product, is under …See details»
Management | InMed Pharmaceuticals Inc.
Netta has also previously held roles at Angiotech Pharmaceuticals, Inc. (NASDAQ: ANP) and Ernst & Young. Netta is a Chartered Professional Accountant with the Institute of Chartered …See details»
InMed Pharmaceuticals - Crunchbase Company Profile & Funding
InMed Pharmaceuticals is a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates.See details»
InMed Pharmaceuticals - Overview, News & Similar companies
May 22, 2024 InMed Pharmaceuticals contact info: Phone number: (604) 669-7207 Website: www.inmedpharma.com What does InMed Pharmaceuticals do? Founded in 1981, InMed …See details»
InMed Pharmaceuticals Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for InMed Pharmaceuticals Inc of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
InMed Pharmaceuticals - LinkedIn
#News: InMed announces peer-reviewed publication of company-sponsored study on anti-inflammation by modulation of #endocannabinoid system. “This important research into …See details»
InMed Pharmaceuticals - LinkedIn
InMed Pharmaceuticals is a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. InMed’s pipeline …See details»
InMed Pharmaceuticals Information - RocketReach
Inmedpharma.com; View Similar People. Related Companies Ayogo Health Inc. 17 $6.8m Syreon: Celebrating 20 Years of Leading Research. 42 $22.1m Michael Smith Health Research BC. 83 …See details»
Board of Directors | InMed Pharmaceuticals Inc.
Andy received a bachelor’s degree in Biology from Kenyon College in 1985. He recently served as a member and chair of the Board of Directors of the Illinois Biotechnology Innovation Organization, a recent Board member of Zucara …See details»
InMed Pharmaceuticals - PitchBook
InMed Pharmaceuticals General Information Description. InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research …See details»
InMed Pharmaceuticals - Craft
Oct 29, 2024 InMed Pharmaceuticals has 5 employees across 2 locations and $4.6 m in annual revenue in FY 2024. See insights on InMed Pharmaceuticals including office locations, …See details»
InMed Pharmaceuticals (INM) Stock Price, News & Analysis
6 days ago www.inmedpharma.com. Phone 604-669-7207. Fax N/A. Employees 13. Year Founded N/A. Profitability. EPS (Most Recent Fiscal Year) ($13.91) Trailing P/E Ratio N/A. …See details»
InMed and Almac Group Developing Improved Cannabinoid …
May 5, 2020 Almac is an international, privately-owned organization which has grown organically over the past five decades now employing over 5,600 highly skilled personnel across 18 …See details»
Investor Relations - InMed Pharmaceuticals
InMed Pharmaceuticals Investor Relations Webpage, News, Corporate Presentation, Investor Conferences, Media and VideosSee details»
InMed Pharmaceuticals Signs Definitive Agreement to Acquire
Sep 13, 2021 Establishes leadership position in manufacturing and commercialization of rare cannabinoids; Positions InMed within large and growing consumer health and wellness …See details»
InMed Pharmaceuticals Inc. (INM) Stock Price, News, Quote
Find the latest InMed Pharmaceuticals Inc. (INM) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Corporate Presentation - November 2024 - InMed Pharmaceuticals
View InMed's corporate investor presentation. Learn about InMed's investor highlights, pharmaceutical programs and investor profile.See details»
INM Stock Price Quote | Morningstar
6 days ago See the latest InMed Pharmaceuticals Inc stock price (INM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.See details»
InMed Pharmaceuticals Strengthens Executive Leadership Team …
Vancouver, British Columbia–(Newsfile Corp. – February 9, 2024) – InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the “Company”), a leader in the manufacturing, development and …See details»